Source link : https://www.newshealth.biz/health-news/fda-expands-approval-of-severe-asthma-drug/
The FDA expanded the approval of benralizumab (Fasenra) to include treatment of younger kids with uncontrolled severe asthma with an eosinophilic phenotype, AstraZeneca announced on Thursday. Previously approved for individuals 12 and up, the broader indication now allows for use of the injectable add-on maintenance therapy in patients ages 6 to 11 years as well. […]
Author : News Health
Publish date : 2024-04-11 19:44:01
Copyright for syndicated content belongs to the linked Source.